This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Damilola Daniel Phillips: Innovator in Targeted Delivery Systems
Introduction
Damilola Daniel Phillips is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted delivery systems for therapeutic compounds. His innovative approach has the potential to enhance the efficacy of treatments for various diseases.
Latest Patents
Damilola Daniel Phillips holds a patent for an invention titled "Engineered anthrax lethal toxin for targeted delivery." This invention provides methods and systems for the targeted delivery of a compound to a target cell that over-expresses two different proteinases. The invention involves administering two modified protective antigen proteins, which form a hetero-oligomer upon cleavage by the proteinases, allowing the compound to bind and be translocated into the target cell. This patent represents a significant advancement in targeted therapy.
Career Highlights
Phillips is currently associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work focuses on innovative solutions that address critical health challenges through advanced biotechnological methods. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Damilola Daniel Phillips has collaborated with esteemed colleagues such as Stephen H. Leppla and Clinton Edward Leysath. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Damilola Daniel Phillips is a pioneering inventor whose work in targeted delivery systems has the potential to revolutionize therapeutic approaches. His contributions to biotechnology are noteworthy, and his patent reflects a commitment to improving health outcomes through innovative solutions.
